RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Assembly Biosciences Stock

Assembly Biosciences ROCE 2024

Assembly Biosciences ROCE

-1.57

Ticker

ASMB

ISIN

US0453961080

WKN

A117S1

In 2024, Assembly Biosciences's return on capital employed (ROCE) was -1.57, a 39.79% increase from the -1.13 ROCE in the previous year.

Assembly Biosciences Aktienanalyse

What does Assembly Biosciences do?

Assembly Biosciences Inc is an innovative biotechnology company specializing in the development of new therapies for infectious diseases and gastrointestinal disorders. The company was founded in 2005 and is headquartered in South San Francisco, California. The company's business model focuses on the discovery and development of new drugs for infectious diseases and gastrointestinal disorders, with a goal of establishing a strong pipeline of innovative therapeutics. The company's research activities are divided into two main areas: infectious diseases and gastrointestinal disorders. The company currently has no products on the market but is in the development phase of its pipeline. Assembly Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Assembly Biosciences's Return on Capital Employed (ROCE)

Assembly Biosciences's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Assembly Biosciences's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Assembly Biosciences's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Assembly Biosciences’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Assembly Biosciences stock

What is the ROCE (Return on Capital Employed) of Assembly Biosciences this year?

The ROCE of Assembly Biosciences is -1.57 undefined this year.

How has the ROCE (Return on Capital Employed) of Assembly Biosciences developed compared to the previous year?

The ROCE of Assembly Biosciences has increased by 39.79% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Assembly Biosciences?

A high Return on Capital Employed (ROCE) indicates that Assembly Biosciences has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Assembly Biosciences?

A low ROCE (Return on Capital Employed) can indicate that Assembly Biosciences has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Assembly Biosciences impact the company?

An increase in the ROCE of Assembly Biosciences can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Assembly Biosciences affect the company?

A decrease in ROCE of Assembly Biosciences can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Assembly Biosciences?

Some factors that can affect Assembly Biosciences's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Assembly Biosciences so important for investors?

The ROCE of Assembly Biosciences is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Assembly Biosciences take to improve the ROCE?

To improve the ROCE, Assembly Biosciences can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Assembly Biosciences pay?

Over the past 12 months, Assembly Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Assembly Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Assembly Biosciences?

The current dividend yield of Assembly Biosciences is .

When does Assembly Biosciences pay dividends?

Assembly Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Assembly Biosciences?

Assembly Biosciences paid dividends every year for the past 0 years.

What is the dividend of Assembly Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Assembly Biosciences located?

Assembly Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Assembly Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Assembly Biosciences from 11/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/25/2024.

When did Assembly Biosciences pay the last dividend?

The last dividend was paid out on 11/25/2024.

What was the dividend of Assembly Biosciences in the year 2023?

In the year 2023, Assembly Biosciences distributed 0 USD as dividends.

In which currency does Assembly Biosciences pay out the dividend?

The dividends of Assembly Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Assembly Biosciences

Our stock analysis for Assembly Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Assembly Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.